- Home
- NATR vs CLLS Comparison
NATR vs CLLS Comparison
Compare NATR & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | CLLS |
|---|---|---|
| Founded | 1972 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.0M | 394.4M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NATR | CLLS |
|---|---|---|
| Price | $13.21 | $1.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $28.33 | $8.33 |
| AVG Volume (30 Days) | ★ 153.6K | 117.1K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $480,144,000.00 | N/A |
| Revenue This Year | $7.76 | N/A |
| Revenue Next Year | $4.82 | $0.98 |
| P/E Ratio | $27.52 | ★ N/A |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $12.97 | $2.35 |
| 52 Week High | $28.14 | $5.48 |
Technical Indicators
Market Signals| Indicator | NATR | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 22.78 | 19.21 |
| Support Level | N/A | N/A |
| Resistance Level | $21.17 | $3.47 |
| Average True Range (ATR) | 0.39 | 0.21 |
| MACD | 0.14 | -0.18 |
| Stochastic Oscillator | 2.80 | 2.93 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.